CVS Health shares fell 2.6% in pre-conference trading, as the healthcare and pharmacy company announced fourth-quarter results that exceeded expectations, but provided a mixed outlook for the year as a whole.
Net income rose to $ 1.31 billion, or 98 cents a share, from $ 873 million, or 74 cents a year, a year earlier.
Excluding the extraordinary, the adjusted earnings per share of $ 1.98 were higher than the convergent estimates for $ 1.83. Revenue rose 10.1 percent to $ 76.60, compared with estimates for $ 75.66 billion.
The company said it provided more than 20 million coronavirus vaccines during the quarter, and more than 8 million coronavirus tests.
For 2022, the company confirmed the adjusted earnings per share estimates at $ 8.10-8.30, compared to the convergent estimates for $ 8.27.
However, it revised its outlook for cash flow lower, to $ 12-13 billion from $ 12.5-13 billion.
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
